A meta‐analysis reported that IL‐6 and sVCAM‐1 levels are higher in T2DM patients with cognitive impairment, indicating an increased inflammatory‐vascular interaction associated with cognitive dysfunction in T2DM (Anita et al. Here, IL6 is linked to type 2 diabetes mellitus.